Tower Research Capital »

Ernexa Therapeutics shares owned by Tower Research Capital

Quarter-by-quarter ownership of Ernexa Therapeutics (ERNA) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Ernexa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ernexa Therapeutics held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ernexa Therapeutics by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $5.7k 5.2k 1.09

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Ernexa Therapeutics

CI Private Wealth
Susquehanna International
Geode Capital Management
Vanguard Group
Sippican Capital Adivsors
Tower Research Capital
BlackRock
Morgan Stanley
Assetmark
EverSource Wealth Advisors
Bnp Paribas Arbitrage, Snc
A. Montag and Associates
Activest Wealth Management

View all funds holding Ernexa Therapeutics